Home / Pharmaceutical company intelligence
Titlis Pharma (Private) Limited site mark
Pharmaceutical company intelligence

Titlis Pharma products and prices in Pakistan

Manufacturer & importer Has products under both a manufacturing licence (DML) and a sale licence (DSL). Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore pharmaceutical manufacturer established in 2014 with GMP/ISO-oriented production, contract manufacturing and export activity.

Titlis Pharma products in Pakistan

Titlis Pharma (Private) Limited has 60 medicine presentations registered in Pakistan under 21 brands, covering 22 generic medicines. Most of its products are in Anti-infectives, Hematology & thrombosis and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are GerEpo (Erythropoietin), Roxalis (Rivaroxaban), Ciprolis (Ciprofloxacin) and Dapatit (Dapagliflozin). 60 products have an official DRAP price on MedInfoBase. See all 21 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date23 Jul 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Private pharmaceutical manufacturer
Address
528-A, Sundar Industrial Estate, Raiwind Road, Lahore, Pakistan
Phone
+92 42 35297692-5; +92 349 4563570
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000799 Titlis Pharma. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000799 52 linked products · source seen 11 Nov 2026 View source ↗
DSL 05-352-0066-035681D 8 linked products · source seen 11 Nov 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx62public portfolio records represented
REG46unique registrations represented
IDX60indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+2registry-only registrations
VER2registry-verified exact registrations
PKR60current validated price records
G22generic molecules in indexed catalogue
DF6dosage-form groups
TA8therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage97%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage95%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixTitlis Pharma (Private) LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/titlis-pharma-private-limitedGenerated 11 Nov 2026Anti-infectives21 · 35%Hematology & thrombosis15 · 25%Vitamins, minerals & nutrition7 · 12%CNS & mental health6 · 10%Endocrine & metabolic5 · 8%Pain & musculoskeletal3 · 5%Gastrointestinal & hepatology2 · 3%Other therapeutic areas1 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioTitlis Pharma (Private) LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/titlis-pharma-private-limitedGenerated 11 Nov 202660presentationsTablet30 · 50%Suspension11 · 18%Injection8 · 13%Capsule7 · 12%Syrup3 · 5%Sachet1 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionTitlis Pharma (Private) LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/titlis-pharma-private-limitedGenerated 11 Nov 202657comparable productsBelow peer median12 · 21%Near peer median26 · 46%Above peer median19 · 33%Company median price position+2.7%Lowest-price equivalents5Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsTitlis Pharma (Private) LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/titlis-pharma-private-limitedGenerated 11 Nov 2026Shaigan Pharmaceuticals (Pvt) Ltd17 shared77% overlapGlitz Pharma16 shared73% overlapZephyr Pharmatec (pvt) limited16 shared73% overlapMacter International Limited15 shared68% overlapBio-Labs(Pvt) Ltd15 shared68% overlapNeutro Pharma (Pvt.) Ltd.,15 shared68% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives21 products · 35%
Hematology & thrombosis15 products · 25%
Vitamins, minerals & nutrition7 products · 12%
CNS & mental health6 products · 10%
Endocrine & metabolic5 products · 8%
Pain & musculoskeletal3 products · 5%
Gastrointestinal & hepatology2 products · 3%
Fluids & supportive care1 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Erythropoiesis-stimulating agents8 products · 13%
Macrolide antibacterials7 products · 12%
Fluoroquinolone antibacterials7 products · 12%
Vitamins / minerals / hematinics7 products · 12%
Anticoagulants7 products · 12%
Antiepileptics6 products · 10%
Antidiabetic medicines5 products · 8%
Analgesics / NSAIDs3 products · 5%
Formulation footprint

Dosage forms

Tablet30 products
Suspension11 products
Injection8 products
Capsule7 products
Syrup3 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 GerEpoErythropoietin 8presentations 2000 IU, 3000 IU, 4000 IU, 5000 IU · Injection #2 RoxalisRivaroxaban 7presentations 10 mg, 15 mg, 2.5 mg, 20 mg · Tablet #3 CiprolisCiprofloxacin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #4 DapatitDapagliflozin 4presentations 10 mg, 5 mg · Tablet #5 LVTLevetiracetam 4presentations 250 mg, 500 mg · Tablet #6 RespiklarClarithromycin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Titlis Pharma (Private) Limited is priced against the market

57 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Shaigan Pharmaceuticals (Pvt) Ltd207 products · 80 generics 17shared generics Glitz Pharma166 products · 71 generics 16shared generics Zephyr Pharmatec (pvt) limited85 products · 38 generics 16shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers44Distinct registrations among indexed, published, presentation-validated products only
Verified price observations60
Products with a verified price60
Products with multiple price observations0
Source records with multiple versions60
Latest portfolio source check22 Sep 2026
Latest effective price date23 Jul 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

46 unique registration(s) · 60 indexed presentation(s) · 2 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Azipos Azithromycin 250 mg Capsule 10'S 078812 PKR 508.66 PKR 50.87/capsule 🔒 Pharma Pro
Azipos Azithromycin 500 mg Tablet 6's 102618 PKR 441.57 PKR 73.60/tablet 🔒 Pharma Pro
Azipos Azithromycin 200 mg/5 mL Suspension 15ml 115425 PKR 340.79 PKR 22.72/mL 🔒 Pharma Pro
Carbatit Carbamazepine 200 mg Tablet 30's 119316 PKR 340.78 PKR 11.36/tablet 🔒 Pharma Pro
Carbatit Carbamazepine 200 mg Tablet 50's 119316 PKR 540.84 PKR 10.82/tablet 🔒 Pharma Pro
Ciprolis Ciprofloxacin 500 mg Tablet 10's 078821 PKR 437.79 PKR 43.78/tablet 🔒 Pharma Pro
Ciprolis Ciprofloxacin 250 mg Tablet 10's 085179 PKR 264.70 PKR 26.47/tablet 🔒 Pharma Pro
Ciprolis Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 116676 PKR 222.36 PKR 3.71/mL 🔒 Pharma Pro
Ciprolis Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 116677 PKR 330.46 PKR 5.51/mL 🔒 Pharma Pro
Conazit Fluconazole 150 mg Capsule 4's 078813 PKR 1,013.31 PKR 253.33/capsule 🔒 Pharma Pro
Conazit Fluconazole 150 mg Capsule 1's 078813 PKR 281.00 PKR 281.00/capsule 🔒 Pharma Pro
Dapatit Dapagliflozin 5 mg Tablet 14's 115200 PKR 1,461.19 PKR 104.37/tablet 🔒 Pharma Pro
Dapatit Dapagliflozin 5 mg Tablet 10's 115200 PKR 1,043.04 PKR 104.30/tablet 🔒 Pharma Pro
Dapatit Dapagliflozin 10 mg Tablet 14's 115201 PKR 1,543.42 PKR 110.24/tablet 🔒 Pharma Pro
Dapatit Dapagliflozin 10 mg Tablet 10's 115201 PKR 1,101.77 PKR 110.18/tablet 🔒 Pharma Pro
GerEpo Erythropoietin 2000 IU Injection 1's Vial 084786 PKR 2,090.69 PKR 2,090.69/vial/unit 🔒 Pharma Pro
GerEpo Erythropoietin 3000 IU Injection 1's Vial 084787 PKR 3,158.18 PKR 3,158.18/vial/unit No comparator
GerEpo Erythropoietin 4000 IU Injection 1's Vial 084788 PKR 3,983.85 PKR 3,983.85/vial/unit 🔒 Pharma Pro
GerEpo Erythropoietin 5000 IU Injection 1's Vial 084789 PKR 5,149.56 PKR 5,149.56/vial/unit No comparator
GerEpo Erythropoietin 2000 IU Prefilled syringe injection 1's PFS 084790 PKR 2,090.69 PKR 2,090.69/syringe 🔒 Pharma Pro
GerEpo Erythropoietin 3000 IU Prefilled syringe injection 1's PFS 084791 PKR 3,158.18 PKR 3,158.18/syringe No comparator
GerEpo Erythropoietin 4000 IU Prefilled syringe injection 5's 084792 PKR 18,222.28 PKR 3,644.46/syringe 🔒 Pharma Pro
GerEpo Erythropoietin 4000 IU Prefilled syringe injection 1's PFS 084792 PKR 3,983.85 PKR 3,983.85/syringe 🔒 Pharma Pro
Ibulis Liquid Ibuprofen 200 mg/5 mL Suspension 90ml 078814 PKR 125.34 PKR 1.39/mL 🔒 Pharma Pro
Ibulis Liquid Ibuprofen 100 mg/5 mL Suspension 90 ml 078815 PKR 87.52 PKR 0.97/mL 🔒 Pharma Pro
Ibulis Liquid Ibuprofen 100 mg/5 mL Suspension 120 ml 078815 PKR 135.50 PKR 1.13/mL 🔒 Pharma Pro
Irobest Iron polymaltose complex 50 mg/5 mL Syrup 60ml 078816 PKR 151.36 PKR 2.52/mL 🔒 Pharma Pro
Irobest Iron polymaltose complex 50 mg/5 mL Syrup 120ml 078816 PKR 273.96 PKR 2.28/mL 🔒 Pharma Pro
Irobest-F Iron polymaltose complex + Folic acid 100 mg elemental iron + 0.35 mg folic acid Chewable tablet 10's 085840 PKR 168.89 PKR 16.89/tablet 🔒 Pharma Pro
Irobest-F Iron polymaltose complex + Folic acid 100 mg + 0.35 mg Chewable tablet 30's 085840 PKR 457.86 PKR 15.26/tablet 🔒 Pharma Pro
Irobest-F Elemental Iron 100 mg Chewable tablet 20's 085840 PKR 311.59 PKR 15.58/tablet 🔒 Pharma Pro
Irotit Polysaccharide iron complex 100 mg/5 mL Syrup 120ml 110606 PKR 176.58 PKR 1.47/mL 🔒 Pharma Pro
Irotit Polysaccharide iron complex 150 mg Capsule 30's 110607 PKR 466.18 PKR 15.54/capsule 🔒 Pharma Pro
Levolis Levofloxacin 500 mg Tablet 10's 078820 PKR 829.79 PKR 82.98/tablet 🔒 Pharma Pro
Levolis Levofloxacin 250 mg Tablet 10's 085178 PKR 498.67 PKR 49.87/tablet 🔒 Pharma Pro
Lisformin Metformin 500 mg Tablet 50's 078823 PKR 133.70 PKR 2.67/tablet 🔒 Pharma Pro
Lopilis 200 Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 106020 PKR 11,525.21 PKR 96.04/tablet 🔒 Pharma Pro
LVT Levetiracetam 250 mg Tablet 30's 102616 PKR 1,441.19 PKR 48.04/tablet 🔒 Pharma Pro
LVT Levetiracetam 250 mg Tablet 10's 102616 PKR 480.40 PKR 48.04/tablet 🔒 Pharma Pro
LVT Levetiracetam 500 mg Tablet 30's 102617 PKR 2,389.77 PKR 79.66/tablet 🔒 Pharma Pro
LVT Levetiracetam 500 mg Tablet 10's 102617 PKR 796.59 PKR 79.66/tablet 🔒 Pharma Pro
Metrolis Metronidazole 200 mg/5 mL Oral suspension 90ml 078818 PKR 99.02 PKR 1.10/mL 🔒 Pharma Pro
Metrolis Metronidazole 200 mg/5 mL Oral suspension 120ml 078818 PKR 135.57 PKR 1.13/mL 🔒 Pharma Pro
Metrolis Metronidazole 200 mg/5 mL Oral suspension 60 ml 078818 PKR 69.17 PKR 1.15/mL 🔒 Pharma Pro
Moxilis Moxifloxacin 400 mg Tablet 5's 078824 PKR 947.48 PKR 189.50/tablet 🔒 Pharma Pro
Omsta Omeprazole 20 mg Capsule 14's 078871 PKR 297.40 PKR 21.24/capsule 🔒 Pharma Pro
Omsta Omeprazole 40 mg Capsule 14's 097530 PKR 401.43 PKR 28.67/capsule 🔒 Pharma Pro
ORS Sodium chloride 2.60 g Sachet 20's 121493 PKR 521.15 PKR 26.06/sachet 🔒 Pharma Pro
Oselvir Oseltamivir 75 mg Capsule 10's 106021 PKR 1,125.51 PKR 112.55/capsule 🔒 Pharma Pro
Respiklar Clarithromycin 250 mg Tablet 10's 093552 PKR 465.97 PKR 46.60/tablet 🔒 Pharma Pro
A to Z

All 21 Titlis Pharma brands in Pakistan

  • Azipos Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
  • Carbatit Carbamazepine · 200 mg tablet
  • Ciprolis Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
  • Conazit Fluconazole · 150 mg capsule
  • Dapatit Dapagliflozin · 10 mg tablet, 5 mg tablet
  • GerEpo Erythropoietin · 2000 IU injection, 3000 IU injection, 4000 IU injection
  • Ibulis Liquid Ibuprofen · 100 mg/5 mL suspension, 200 mg/5 mL suspension
  • Irobest Iron polymaltose complex · 50 mg/5 mL syrup
  • Irobest-F Elemental Iron, Iron polymaltose complex + Folic acid · 100 mg tablet, 100 mg + 0.35 mg tablet, 100 mg elemental iron + 0.35 mg folic acid tablet
  • Irotit Polysaccharide iron complex · 100 mg/5 mL syrup, 150 mg capsule
  • Levolis Levofloxacin · 250 mg tablet, 500 mg tablet
  • Lisformin Metformin · 500 mg tablet
  • Lopilis 200 Lopinavir + Ritonavir · 200 mg + 50 mg tablet
  • LVT Levetiracetam · 250 mg tablet, 500 mg tablet
  • Metrolis Metronidazole · 200 mg/5 mL suspension
  • Moxilis Moxifloxacin · 400 mg tablet
  • Omsta Omeprazole · 20 mg capsule, 40 mg capsule
  • ORS Sodium chloride · 2.60 g sachet
  • Oselvir Oseltamivir · 75 mg capsule
  • Respiklar Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
  • Roxalis Rivaroxaban · 10 mg tablet, 15 mg tablet, 2.5 mg tablet
Questions

Titlis Pharma: common questions

How many products does Titlis Pharma have in Pakistan?

Titlis Pharma (Private) Limited has 60 registered medicine presentations in Pakistan, sold under 21 brands and covering 22 generic medicines.

What are the main brands of Titlis Pharma?

By number of registered strengths and packs, its largest brands are GerEpo (Erythropoietin), Roxalis (Rivaroxaban), Ciprolis (Ciprofloxacin), Dapatit (Dapagliflozin) and LVT (Levetiracetam). This is not a sales ranking.

Which therapy areas does Titlis Pharma cover?

The most products are in Anti-infectives (21), Hematology & thrombosis (15), Vitamins, minerals & nutrition (7), CNS & mental health (6) and Endocrine & metabolic (5).

Where can I see Titlis Pharma medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Titlis Pharma (Private) Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/titlis-pharma-private-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9